Al Shroouk Scan & Lab is eyeing a USD 20 mn expansion drive over the next four years as it gears up for an EGX listing, Chairman Abdallah Mostafa tells Zawya. The diagnostic imaging company plans to grow its footprint from five to eight branches by 2030, including a USD 8 mn Palm Hills branch, a dedicated radiotherapy center in the New Capital’s R3 District, and new facilities in New Cairo, Alexandria, Shebin El Kom, and Tanta.
The move toward advanced cancer care is expected to drastically transform the company’s financials. Mostafa expects the new radiotherapy capabilities to drive up revenues by 200% annually once the facilities come online. The group’s current top line stands at approximately EGP 140 mn, supported by established contracts with major healthcare operators like Cleopatra Hospital Group.
The backstory: Founded in 2009, Al Shroouk has steadily built out its diagnostic infrastructure, investing around EGP 1 bn to date. The company was formally structured in 2014 with an initial capital of EGP 3.2 mn and early strategic backing from the Bedaya Fund for SMEs, which acquired a 33% stake.